1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 2005; 193: 860-863. [
DOI:10.1016/j.ajog.2005.06.058]
2. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap LC, Wenstrom KD. Williams Obstetrics. 22th ed. Philadelfia: McGraw Hill; 2005: 765-768.
3. Vahid Roudsari F, Ayati S, Torabizadeh A, Ayatollahi H, Esmaeli H, Shahabian M. Serum calcium and magnesium in preeclamptic and normal pregnancies; A comparative study. Journal of Reproduction & Infertility 2008; 9: 256-262.
4. Mirahmadian M, Kalantar F, Heidari G, Safdarian L, Mansouri R, Amirzargar AA. Association of tumor necrosis factor-alpha and interlukine-10 gene polymorphisms in Iranian patients with preeclampsia. Am J Reprod Immunol 2008; 60: 179- 185. [
DOI:10.1111/j.1600-0897.2008.00610.x]
5. Gulti R. Raised serum TNF-alpha, blood sugar and uric asid in preeclampsia in third trimester of pregnancy. J Nep Med Assoc 2005; 44: 36-38. [
DOI:10.31729/jnma.393]
6. Sibai BM. Immunological aspects of preeclampsia. Clin Obstet Gynaecol 1991; 34: 27-34. [
DOI:10.1097/00003081-199103000-00007]
7. Tranchot-Diallo J, Gras G, Parnet-Mathieu f, Benveniste O, Marce D, Roques P, et al. Modulations of cytokine expression in pregnant women. Am J Reprod Immunol 1997; 37: 215-226. [
DOI:10.1111/j.1600-0897.1997.tb00218.x]
8. Kaumma S, Matt D, Sytrom S, Eierman D, Turner T. Interlukin-1beta, human leukocyte antigen HLA-DR alpha, and transforming growth factor-beta expression in endometrium, placenta and placental membranes. Am J Obstet Gynecol 1990; 163: 1430-1437. [
DOI:10.1016/0002-9378(90)90601-3]
9. Hunt JS. Cytokines network in uteroplacental unit, macrophages as pivotal regulatory cell. J Reprod Immunol 1989; 16: 1-17. [
DOI:10.1016/0165-0378(89)90002-8]
10. Ari KI, Lee F, Miyajima A, Miyatake S, Ari N, Yokata T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 1990; 59: 783-836. [
DOI:10.1146/annurev.bi.59.070190.004031]
11. Sharma A, Satyam A, Sharma JB. Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 2007; 58: 21-30. [
DOI:10.1111/j.1600-0897.2007.00486.x]
12. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163:740-745. [
DOI:10.1084/jem.163.3.740]
13. Kupfermink MJ, Peaceman AM, Wington TR, Tamura RK, Rehnberg KA, Socol ML. Immunoreactive tumor necrosis factor-alpha is elevated in maternal plasma but undetected in amniotic fluid in the second trimester. Am J Obstet Gynecol 1994; 171: 976-979. [
DOI:10.1016/0002-9378(94)90017-5]
14. Vallance P, Collier J, Bhagat K. Infection, inflammation and infraction: dose acute endothelial dysfunction provide a link? Lancet 1997; 349: 1391-1392. [
DOI:10.1016/S0140-6736(96)09424-X]
15. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Mclaughlin MK, Hubel CA. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-1204. [
DOI:10.1016/0002-9378(89)90665-0]
16. Herrera JA, Chaudhuri G, Lopez-Jaramillo P. Is infection a major risk factor for preeclampsia? Med Hypotheses 2001; 57: 393-397. [
DOI:10.1054/mehy.2001.1378]
17. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia. Int J Gynecol Obstet 2001; 75: 243-249. [
DOI:10.1016/S0020-7292(01)00499-4]
18. Tavakol Afshari J, Ghomian N, Shameli A, Shakeri MT, Fahmidehkar MA, Mahajer E, et al. Determination of interlukin-6 and tumor necrosis factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia. BMC Pregnancy and Childbirth 2005; 5: 14. [
DOI:10.1186/1471-2393-5-14]
19. Kocyigity Y, Atamer Y, Atamer A, Tuzcu A, Akkus Z. Changes in serum levels of leptin, cytokines and lipoprotein in preeclamptic and normotensive pregnant women. Gynecol Endocrinol 2004; 19: 267-273. [
DOI:10.1080/09513590400018108]
20. Hamai Y, Fujii T, Yamashita T, Nishina H, Kozuma S, Mikami Y et al. Evidence for an elevation in serum interlukine-2 and tumour necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997; 38: 89-93. [
DOI:10.1111/j.1600-0897.1997.tb00281.x]
21. Omu AE, Al-Qattan F, Diejomach ME, Al-Yatama M. Differential levels of T helper cytokines in preeclampsia: pregnancy, labor and puerperium. Acta Obstet Gynecol Scand 1999; 78: 675-680. [
DOI:10.1034/j.1600-0412.1999.780803.x]
22. Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Payser Mr, Lessing JB, Socol ML. Soluble tumor necrosis factor receptors in maternal plasma and second-trimester amniotic fluid. A J Obstet Gynecol 1995; 173: 900-905. [
DOI:10.1016/0002-9378(95)90363-1]
23. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia. Int J Gynaecol Obstet 2001; 75: 243-249. [
DOI:10.1016/S0020-7292(01)00499-4]
24. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interlukin-6 and interlukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol 1994; 84: 937-940.
25. Heyl W, Handt S, Reister F, Gehlen J. Elevated soluble adhesion molecules in women with preeclampsia. Do cytokines like tumor necrosis factor-alpha and interlukin-1 beta cause endothelial activation. Eur J Obstet Gynecol Reprod Biol 1999; 86: 35-41. [
DOI:10.1016/S0301-2115(99)00042-1]
26. Ellis J, Wennerholm UB, Bengtsson A, Lilja H, Pettersson A, Sultan B, et al . Levels of dimethyl-arginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 2001; 80: 602-608. [
DOI:10.1080/j.1600-0412.2001.800703.x]
27. Hill JA, Devoe LD, Bryans CI Jr. Frequency of asymptomatic bacteriuria in preeclampsia. Obstet Gynecol 1986; 67: 529-532.
28. Hsu CD, Witter FR. Urogenital infection in preeclampsia. Int J Gynecol Obstet 1995; 49: 271-275. [
DOI:10.1016/0020-7292(95)02373-K]